These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32744979)

  • 1. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
    Choppavarapu L; Kandi SM
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating biomarkers for high-grade glioma.
    Loo HK; Mathen P; Lee J; Camphausen K
    Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum microRNAs as potential noninvasive biomarkers for glioma.
    Yu X; Li Z
    Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
    Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients.
    Li Z; Ye L; Wang L; Quan R; Zhou Y; Li X
    Ann Diagn Pathol; 2020 Feb; 44():151436. PubMed ID: 31865249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA is a biomarker for post-operative monitoring in glioma.
    Morokoff A; Jones J; Nguyen H; Ma C; Lasocki A; Gaillard F; Bennett I; Luwor R; Stylli S; Paradiso L; Koldej R; Paldor I; Molania R; Speed TP; Webb A; Infusini G; Li J; Malpas C; Kalincik T; Drummond K; Siegal T; Kaye AH
    J Neurooncol; 2020 Sep; 149(3):391-400. PubMed ID: 32915353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Biomarkers for Glioma: A Review.
    Jones J; Nguyen H; Drummond K; Morokoff A
    Neurosurgery; 2021 Feb; 88(3):E221-E230. PubMed ID: 33442748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA biomarkers for glioma and predicting response to therapy.
    Tumilson CA; Lea RW; Alder JE; Shaw L
    Mol Neurobiol; 2014 Oct; 50(2):545-58. PubMed ID: 24696266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating biomarkers for gliomas.
    Westphal M; Lamszus K
    Nat Rev Neurol; 2015 Oct; 11(10):556-66. PubMed ID: 26369507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas].
    Gareev IF; Novicova LB; Beylerli OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):86-90. PubMed ID: 31317895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
    Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
    J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.
    Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S
    Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Cancer Sci; 2018 Sep; 109(9):2651-2659. PubMed ID: 29949235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based biomarkers for the diagnosis and monitoring of gliomas.
    Zachariah MA; Oliveira-Costa JP; Carter BS; Stott SL; Nahed BV
    Neuro Oncol; 2018 Aug; 20(9):1155-1161. PubMed ID: 29746665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
    Santangelo A; Imbrucè P; Gardenghi B; Belli L; Agushi R; Tamanini A; Munari S; Bossi AM; Scambi I; Benati D; Mariotti R; Di Gennaro G; Sbarbati A; Eccher A; Ricciardi GK; Ciceri EM; Sala F; Pinna G; Lippi G; Cabrini G; Dechecchi MC
    J Neurooncol; 2018 Jan; 136(1):51-62. PubMed ID: 29076001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.